221 related articles for article (PubMed ID: 27471597)
1. The DKA that wasn't: a case of euglycemic diabetic ketoacidosis due to empagliflozin.
Candelario N; Wykretowicz J
Oxf Med Case Reports; 2016 Jul; 2016(7):144-6. PubMed ID: 27471597
[TBL] [Abstract][Full Text] [Related]
2. SGLT-2 inhibitors and euglycemic diabetic ketoacidosis/diabetic ketoacidosis in FAERS: a pharmacovigilance assessment.
He Z; Lam K; Zhao W; Yang S; Li Y; Mo J; Gao S; Liang D; Qiu K; Huang M; Wu J
Acta Diabetol; 2023 Mar; 60(3):401-411. PubMed ID: 36576563
[TBL] [Abstract][Full Text] [Related]
3. Diabetic Ketoacidosis in Patients with Type 2 Diabetes on Sodium-Glucose Cotransporter-2 Inhibitors - A Case Series.
Sharma PV; Jobanputra YB; Lewin K; Bagatell S; Lichtstein DM
Rev Recent Clin Trials; 2018; 13(2):156-160. PubMed ID: 29542418
[TBL] [Abstract][Full Text] [Related]
4. Empagliflozin-Associated Euglycemic Diabetic Ketoacidosis in a Patient With Type 2 Diabetes Mellitus.
Chauhan S; Manov A; Dhillon GS; Shah P
Cureus; 2023 Jan; 15(1):e33892. PubMed ID: 36819400
[TBL] [Abstract][Full Text] [Related]
5. A Case of Euglycemic Diabetic Ketoacidosis due to Empagliflozin Use in a Patient with Type 1 Diabetes Mellitus.
Bilgin S; Duman TT; Kurtkulagi O; Yilmaz F; Aktas G
J Coll Physicians Surg Pak; 2022 Jul; 32(7):928-930. PubMed ID: 35795946
[TBL] [Abstract][Full Text] [Related]
6. Euglycemic Diabetic Ketoacidosis With Prolonged Glucosuria Associated With the Sodium-Glucose Cotransporter-2 Canagliflozin.
Kelmenson DA; Burr K; Azhar Y; Reynolds P; Baker CA; Rasouli N
J Investig Med High Impact Case Rep; 2017; 5(2):2324709617712736. PubMed ID: 28634592
[TBL] [Abstract][Full Text] [Related]
7. Euglycemic Diabetic Ketoacidosis Induced by Sodium-Glucose Cotransporter-2 Inhibitor Use and Coronary Angiography: A Case Report.
VonTungeln CD; Al Bataineh M
Cureus; 2024 Jan; 16(1):e52122. PubMed ID: 38344581
[TBL] [Abstract][Full Text] [Related]
8. SGLT-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis: A Case Report and a Literature Review.
Mahfooz RS; Khan MK; Al Hennawi H; Khedr A
Cureus; 2022 Jun; 14(6):e26267. PubMed ID: 35911365
[TBL] [Abstract][Full Text] [Related]
9. Self-Induced Euglycemic Diabetic Ketoacidosis: When to Stop the Drip.
Zughaib MT; Patel K; Leka M; Affas S
Cureus; 2022 Jan; 14(1):e21768. PubMed ID: 35251838
[TBL] [Abstract][Full Text] [Related]
10. A Rare Case of Empagliflozin-Induced Euglycemic Diabetic Ketoacidosis Obscured by Alkalosis.
Fernandez Felix DA; Madrigal Loria G; Sharma S; Sharma S; Arias Morales CE
Cureus; 2022 Jun; 14(6):e25818. PubMed ID: 35698468
[TBL] [Abstract][Full Text] [Related]
11. Post-surgical Euglycemic Diabetic Ketoacidosis in a Patient on Empagliflozin in the Intensive Care Unit.
Bteich F; Daher G; Kapoor A; Charbek E; Kamel G
Cureus; 2019 Apr; 11(4):e4496. PubMed ID: 31259114
[TBL] [Abstract][Full Text] [Related]
12. A series of diabetic ketoacidosis associated with the use of sodium-glucose co-transporter-2 inhibitors in secondary care.
Taverner S; Eng C; Watson R; George S; Edwards A; Williams DM; Stephens JW
Diabetes Metab Syndr; 2022 Dec; 16(12):102658. PubMed ID: 36371968
[TBL] [Abstract][Full Text] [Related]
13. SGLT2 Inhibitors: A Systematic Review of Diabetic Ketoacidosis and Related Risk Factors in the Primary Literature.
Burke KR; Schumacher CA; Harpe SE
Pharmacotherapy; 2017 Feb; 37(2):187-194. PubMed ID: 27931088
[TBL] [Abstract][Full Text] [Related]
14. Euglycemic Diabetic Ketoacidosis in a 27 year-old female patient with type-1-Diabetes treated with sodium-glucose cotransporter-2 (SGLT2) inhibitor Canagliflozin.
Bader N; Mirza L
Pak J Med Sci; 2016; 32(3):786-8. PubMed ID: 27375734
[TBL] [Abstract][Full Text] [Related]
15. Euglycemic Diabetic Ketoacidosis after a Single Dose of Empagliflozin in a Patient with Pancreatitis.
Calçada MB; Fernandes L; Soares Costa R; Montezinho S; Martins Duarte F; Frutuoso L; Freitas AR
Clin Pract; 2021 Apr; 11(2):216-218. PubMed ID: 33917274
[TBL] [Abstract][Full Text] [Related]
16. Acute Pancreatitis-Induced Euglycemic Diabetic Ketoacidosis.
Chaudhry A; Biggiani C; Afzal M; Chaudhry S; Vwich Y
Cureus; 2021 Jun; 13(6):e15949. PubMed ID: 34336446
[TBL] [Abstract][Full Text] [Related]
17. Canagliflozin-associated Diabetic Ketoacidosis with Lower-than-anticipated Glucose Levels.
Vadi S; Agarwal M
Indian J Crit Care Med; 2017 Nov; 21(11):793-795. PubMed ID: 29279644
[TBL] [Abstract][Full Text] [Related]
18. [Risk of Euglycemic Diabetic Ketoacidosis Due to Low-carbohydrate Diet While Taking Empagliflozin: a Case Report].
Yamamoto M; Ide N; Kitajima S; Obayashi M; Asada K; Matsushima S; Ito M
Yakugaku Zasshi; 2019; 139(11):1479-1483. PubMed ID: 31685745
[TBL] [Abstract][Full Text] [Related]
19. Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitor use: a case report and review of the literature.
Diaz-Ramos A; Eilbert W; Marquez D
Int J Emerg Med; 2019 Sep; 12(1):27. PubMed ID: 31488052
[TBL] [Abstract][Full Text] [Related]
20. Sodium-glucose Cotransporter 2 Inhibitors and the Risk of Diabetic Ketoacidosis; from Pathophysiology to Clinical Practice.
Patoulias D; Manafis A; Mitas C; Avranas K; Lales G; Zografou I; Sambanis C; Karagiannis A
Cardiovasc Hematol Disord Drug Targets; 2018; 18(2):139-146. PubMed ID: 29412120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
